Table 2 Clinical and blood pressure characteristics of participants using blood pressure-lowering medications

From: Impact of hypertension phenotypes on the office and 24-h pulse wave velocity and augmentation index in individuals with or without antihypertensive medication use

 

CH

WUCH

MUCH

SUCH

(n = 74)

(n = 44)

(n = 22)

(n = 98)

Male sex, n (%)

25 (34)

13 (30)

15 (68)

55 (56)

Age, years

53.6 ± 13.3

54.9 ± 15.2

46.1 ± 13.8

49.9 ± 14.1

Body mass index, k/m2

27.7 ± 3.9

28.1 ± 4.9

28.1 ± 3.7

27.8 ± 5.0

Hypolipemiant med, n (%)

26 (35)

13 (30)

4 (18)

22 (22)

Antidiabetic med, n (%)

9 (12)

6 (14)

1 (5)

12 (12)

Physical activity, n (%)

26 (35)

13 (30)

6 (27)

26 (27)

Current smoking, n (%)

1 (1)

2 (5)

0 (0)

3 (3)

Office SBP, mmHg

121.8 ± 9.8

143.1 ± 16.0*

121.5 ± 12.2†

148.8 ± 15.0*‡

Office DBP, mmHg

78.7 ± 7.6

91.0 ± 10.7*

79.3 ± 9.2†

101.4 ± 11.9*†‡

Office MAP, mmHg

93.1 ± 7.3

108.4 ± 9.0*

93.4 ± 9.1*†

117.2 ± 11.3*†‡

24 h SBP, mmHg

113.9 ± 6.6

118.7 ± 7.0*

123.3 ± 6.5*

133.4 ± 11.1*†‡

24 h DBP, mmHg

70.0 ± 6.2

72.6 ± 5.1

81.2 ± 4.3*†

88.0 ± 8.2*†‡

24 h MAP, mmHg

84.6 ± 5.4

87.9 ± 4.5*

95.2 ± 3.0*†

103.1 ± 8.0*†‡

Daytime SBP, mmHg

116.0 ± 7.3

121.2 ± 8.2*

125.0 ± 6.8*

136.2 ± 10.7*†‡

Daytime DBP, mmHg

72.5 ± 7.0

74.8 ± 5.3

83.4 ± 4.2*†

90.9 ± 8.4*†‡

Daytime MAP, mmHg

87.0 ± 6.2

90.3 ± 5.1

97.2 ± 3.1*†

106.0 ± 8.1*†‡

Nighttime SBP, mmHg

110.4 ± 8.4

114.0 ± 8.3

120.7 ± 8.1*

127.7 ± 17.8*†

Nighttime DBP, mmHg

66.1 ± 6.5

68.6 ± 6.7

77.1 ± 6.5*†

82.9 ± 10.0*†‡

Nighttime MAP, mmHg

80.8 ± 6.4

83.7 ± 6.1

91.7 ± 5.6*†

97.8 ± 11.1*†‡

  1. DBP diastolic blood pressure, SBP systolic blood pressure, MAP mean arterial pressure, med medications, CH controlled hypertension, WUCH white-coat uncontrolled hypertension, MUCH masked uncontrolled hypertension, SUCH sustained uncontrolled hypertension
  2. *P < 0.05 compared with CH; †P < 0.05 compared with WUCH; ‡P < 0.05 compared with MUCH
Back to article page